Pfizer Raises 2025 Profit Outlook Amid Strong Quarterly Results
TL;DR Summary
Pfizer raised its 2025 profit guidance due to cost reductions and strong quarterly performance, surpassing Wall Street estimates with a revenue of $14.65 billion in Q2, and maintaining its revenue forecast despite potential tariffs and drug price pressures.
- Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results CNBC
- Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Was Hiked. Barron's
- Pfizer Ups Profit View as Cost Cuts Offset Lack of Sales Growth Bloomberg.com
- Pfizer: Earnings Meet Pressure (Rating Upgrade) (NYSE:PFE) Seeking Alpha
- Pfizer (PFE) Reports Earnings Tomorrow: What To Expect Yahoo Finance
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
91%
416 → 38 words
Want the full story? Read the original article
Read on CNBC